Siemens Healthineers: Net profit collapses after depreciation
The medical technology group Siemens Healthineers is giving up part of the business of its multi-billion takeover Corindus. The use of vascular operation robots in cardiology – for example in heart attacks – will be discontinued, Siemens Healthineers will now concentrate on the further development of robots for neurology, the Siemens subsidiary announced on Wednesday in Erlangen.
This is reflected in the figures for the second quarter of 2022/23 (as of the end of September) with a depreciation of 329 million euros. Siemens Healthineers paid around one billion euros for Corindus in 2019. The depreciation decimated the net profit in the quarter to 108 (previous year: 583) million euros.
Read more about that here: